Dr. Maryjo Lechowicz, M.D

NPI: 1336256031
Total Payments
$17,639
2024 Payments
$4,232
Companies
7
Transactions
20
Medicare Patients
474
Medicare Billing
$65,838

Payment Breakdown by Category

Consulting$15,480 (87.8%)
Other$1,000.00 (5.7%)
Food & Beverage$624.06 (3.5%)
Travel$520.49 (3.0%)
Education$14.48 (0.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $15,480 4 87.8%
Honoraria $1,000 1 5.7%
Food and Beverage $624.06 10 3.5%
Travel and Lodging $520.49 4 3.0%
Education $14.48 1 0.1%

Top Paying Companies

Company Total Records Latest Year
Kyowa Kirin, Inc. $10,803 12 $0 (2023)
RECORDATI_RARE_DISEASES_INC. $4,080 1 $0 (2024)
Secura Bio, Inc. $1,652 2 $0 (2024)
EUSA Pharma (US) LLC $1,000 1 $0 (2020)
ABBVIE INC. $76.79 2 $0 (2022)
Bausch Health US, LLC $14.48 1 $0 (2021)
Novartis Pharmaceuticals Corporation $13.36 1 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2024 $4,232 2 RECORDATI_RARE_DISEASES_INC. ($4,080)
2023 $38.46 1 Kyowa Kirin, Inc. ($38.46)
2022 $1,577 3 SECURA BIO, INC. ($1,500)
2021 $14.48 1 Bausch Health US, LLC ($14.48)
2020 $1,000 1 EUSA Pharma (US) LLC ($1,000)
2019 $10,764 11 Kyowa Kirin, Inc. ($10,764)
2018 $13.36 1 Novartis Pharmaceuticals Corporation ($13.36)

All Payment Transactions

20 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
10/25/2024 Secura Bio, Inc. COPIKTRA (Drug) Food and Beverage In-kind items and services $151.87 General
Category: ORAL ONCOLOGIC
03/16/2024 RECORDATI_RARE_DISEASES_INC. SYLVANT (Drug) Consulting Fee Cash or cash equivalent $4,080.00 General
Category: ONCOLOGIC AGENT
12/09/2023 Kyowa Kirin, Inc. Poteligeo (Drug) Food and Beverage In-kind items and services $38.46 General
Category: Monoclonal Antibody
12/11/2022 ABBVIE INC. VENCLEXTA (Drug) Food and Beverage In-kind items and services $59.40 General
Category: ONCOLOGY
12/11/2022 ABBVIE INC. VENCLEXTA (Drug) Food and Beverage In-kind items and services $17.39 General
Category: ONCOLOGY
05/26/2022 SECURA BIO, INC. COPIKTRA (Drug), COPIKTRA, COPIKTRA Consulting Fee Cash or cash equivalent $1,500.00 General
Category: Hematology and Oncology
01/08/2021 Bausch Health US, LLC TARGRETIN (Drug) Education In-kind items and services $14.48 General
Category: Oncology
12/09/2020 EUSA Pharma (US) LLC SYLVANT (Drug) Honoraria Cash or cash equivalent $1,000.00 General
Category: Hematology
02/28/2019 Kyowa Kirin, Inc. POTELIGEO (Drug) Travel and Lodging Cash or cash equivalent $35.14 General
Category: MONOCLONAL ANTIBODY
02/28/2019 Kyowa Kirin, Inc. POTELIGEO (Drug) Food and Beverage Cash or cash equivalent $14.02 General
Category: MONOCLONAL ANTIBODY
02/08/2019 Kyowa Kirin, Inc. POTELIGEO (Drug) Consulting Fee Cash or cash equivalent $4,950.00 General
Category: MONOCLONAL ANTIBODY
02/08/2019 Kyowa Kirin, Inc. POTELIGEO (Drug) Food and Beverage In-kind items and services $145.56 General
Category: MONOCLONAL ANTIBODY
02/08/2019 Kyowa Kirin, Inc. POTELIGEO (Drug) Food and Beverage In-kind items and services $65.00 General
Category: MONOCLONAL ANTIBODY
02/08/2019 Kyowa Kirin, Inc. POTELIGEO (Drug) Food and Beverage In-kind items and services $61.44 General
Category: MONOCLONAL ANTIBODY
02/08/2019 Kyowa Kirin, Inc. POTELIGEO (Drug) Food and Beverage In-kind items and services $57.56 General
Category: MONOCLONAL ANTIBODY
02/08/2019 Kyowa Kirin, Inc. POTELIGEO (Drug) Travel and Lodging In-kind items and services $19.75 General
Category: MONOCLONAL ANTIBODY
02/07/2019 Kyowa Kirin, Inc. POTELIGEO (Drug) Travel and Lodging In-kind items and services $396.60 General
Category: MONOCLONAL ANTIBODY
02/07/2019 Kyowa Kirin, Inc. POTELIGEO (Drug) Travel and Lodging In-kind items and services $69.00 General
Category: MONOCLONAL ANTIBODY
01/31/2019 Kyowa Kirin, Inc. POTELIGEO (Drug) Consulting Fee Cash or cash equivalent $4,950.00 General
Category: MONOCLONAL ANTIBODY
04/24/2018 Novartis Pharmaceuticals Corporation KYMRIAH (Biological) Food and Beverage In-kind items and services $13.36 General
Category: ONCOLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 3 92 127 $58,531 $9,439
2022 3 90 139 $61,193 $10,495
2021 7 186 436 $149,385 $33,667
2020 3 106 166 $69,125 $12,236
Total Patients
474
Total Services
868
Medicare Billing
$65,838
Procedure Codes
16

All Medicare Procedures & Services

16 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 48 70 $31,112 $5,038 16.2%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 19 30 $18,644 $3,247 17.4%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 25 27 $8,775 $1,155 13.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 44 81 $33,960 $5,629 16.6%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 26 35 $20,400 $3,748 18.4%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 20 23 $6,833 $1,118 16.4%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 28 136 $45,077 $11,259 25.0%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 25 116 $26,884 $6,464 24.0%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 55 83 $31,595 $6,294 19.9%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 28 48 $25,592 $5,489 21.4%
99205 New patient outpatient visit, total time 60-74 minutes Office 2021 11 11 $7,725 $1,495 19.3%
99239 Hospital discharge day management, more than 30 minutes Facility 2021 17 17 $6,012 $1,404 23.4%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 22 25 $6,500 $1,262 19.4%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 63 103 $36,724 $6,076 16.5%
99215 Established patient office or other outpatient, visit typically 40 minutes Office 2020 32 52 $24,886 $4,637 18.6%
99205 New patient office or other outpatient visit, typically 60 minutes Office 2020 11 11 $7,515 $1,522 20.3%

About Dr. Maryjo Lechowicz, M.D

Dr. Maryjo Lechowicz, M.D is a Hematology healthcare provider based in Atlanta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1336256031.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Maryjo Lechowicz, M.D has received a total of $17,639 in payments from pharmaceutical and medical device companies, with $4,232 received in 2024. These payments were reported across 20 transactions from 7 companies. The most common payment nature is "Consulting Fee" ($15,480).

As a Medicare-enrolled provider, Lechowicz has provided services to 474 Medicare beneficiaries, totaling 868 services with total Medicare billing of $65,838. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.

Practice Information

  • Specialty Hematology
  • Location Atlanta, GA
  • Active Since 08/25/2006
  • Last Updated 02/24/2015
  • Taxonomy Code 207RH0000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1336256031

Products in Payments

  • POTELIGEO (Drug) $10,764
  • SYLVANT (Drug) $5,080
  • COPIKTRA (Drug) $1,652
  • VENCLEXTA (Drug) $76.79
  • Poteligeo (Drug) $38.46
  • TARGRETIN (Drug) $14.48
  • KYMRIAH (Biological) $13.36

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Hematology Doctors in Atlanta